Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Buy
81
HYPMY Quote, Financials, Valuation and Earnings
Last price:
$5.04
Seasonality move
:
2.72%
Day range:
$4.72 - $5.04
52-week range:
$3.04 - $5.18
Dividend yield:
2.17%
P/E ratio:
21.60x
P/S ratio:
2.61x
P/B ratio:
1.39x
Volume:
918
Avg. volume:
15.1K
1-year change:
61.02%
Market cap:
$3.2B
Revenue:
$1.4B
EPS (TTM):
$0.23
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Hypera SA has -- downside to fair value with a price target of -- per share.
HYPMY vs. S&P 500
-
Over the past 5 trading days, Hypera SA has overperformed the S&P 500 by 17.95% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Hypera SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hypera SA has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Hypera SA reported revenues of $408.8M.
Earnings Growth
-
Hypera SA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Hypera SA reported earnings per share of $0.13.
Enterprise value:
4.6B
EV / Invested capital:
--
Price / LTM sales:
2.61x
EV / EBIT:
22.13x
EV / Revenue:
3.73x
PEG ratio (5yr expected):
16.41x
EV / Free cash flow:
42.61x
Price / Operating cash flow:
29.84x
Enterprise value / EBITDA:
17.53x
Gross Profit (TTM):
$666.6M
Return On Assets:
2.97%
Net Income Margin (TTM):
12.04%
Return On Equity:
6.9%
Return On Invested Capital:
3.84%
Operating Margin:
30.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.5B | $1.2B | $345.5M | $408.8M | |
| Gross Profit | $996M | $886.6M | $666.6M | $198.8M | $240.9M | |
| Operating Income | $523M | $424.4M | $207.5M | $80.5M | $123.1M | |
| EBITDA | $565.9M | $476.3M | $262M | $93.1M | $137.6M | |
| Diluted EPS | $0.55 | $0.48 | $0.23 | $0.11 | $0.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.4B | $1.6B | $1.6B | $1.2B | |
| Total Assets | $4B | $4.6B | $5.4B | $5.3B | $5.4B | |
| Current Liabilities | $631.1M | $765.3M | $856.2M | $890.1M | $931.5M | |
| Total Liabilities | $2.3B | $2.6B | $3.1B | $3.1B | $3.1B | |
| Total Equity | $1.8B | $1.9B | $2.3B | $2.2B | $2.3B | |
| Total Debt | $1.2B | $1.4B | $1.6B | $1.6B | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $182.7M | $275.7M | $264.9M | $104.1M | $123.5M | |
| Cash From Investing | -$166.4M | -$105.8M | -$135.7M | -$24.4M | -$23.4M | |
| Cash From Financing | -$19.9M | $22.7M | -$385.1M | -$10.7M | $15M | |
| Free Cash Flow | $11.7M | $136.5M | $107.8M | $71M | $92.2M | |
HYPMY
Sector
Market Cap
$3.2B
$26M
Price % of 52-Week High
97.3%
51.81%
Dividend Yield
2.17%
0%
Shareholder Yield
5.87%
-1.66%
1-Year Price Total Return
61.02%
-18.29%
Beta (5-Year)
0.724
0.485
Dividend yield:
2.17%
Annualized payout:
$0.17
Payout ratio:
26.97%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$4.59
200-day SMA
Buy
Level
$4.38
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$4.37
Relative Strength Index (RSI14)
Buy
Level
59.70
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$4.53
MACD (12, 26)
Buy
Level
0.08
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1531)
Sell
CA Score
(Annual)
Level (-0.4069)
Buy
Beneish M-Score
(Annual)
Level (-2.757)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (0.231)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. It operates through the following segments: Prescription Products, Consumer Health, Similar and Generic Drugs, Skincare, and Institutional Market. The company was founded by João Alves de Queiroz Filho on December 1, 2001 and is headquartered in Sao Paulo, Brazil.
Stock Forecast FAQ
In the current month, HYPMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HYPMY average analyst price target in the past 3 months is --.
-
Where Will Hypera SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hypera SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hypera SA?
Analysts are divided on their view about Hypera SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hypera SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Hypera SA's Price Target?
The price target for Hypera SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HYPMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hypera SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HYPMY?
You can purchase shares of Hypera SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hypera SA shares.
-
What Is The Hypera SA Share Price Today?
Hypera SA was last trading at $5.04 per share. This represents the most recent stock quote for Hypera SA. Yesterday, Hypera SA closed at $5.04 per share.
-
How To Buy Hypera SA Stock Online?
In order to purchase Hypera SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get HYPMY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HYPMY
Sector
P/E ratio
21.60x
23.85x
PEG ratio
16.41x
-0.01x
P/B ratio
1.39x
1.83x
Price / LTM sales
2.61x
1.56x
Growth Metrics
HYPMY
Sector
Revenue growth
18.32%
4.18%
Earnings growth
23.71%
9.66%
Revenue (5-year growth)
10.57%
6.28%
Earnings forecast
--
-$0.18
Profitability
HYPMY
Sector
Profitability FY 2024
$780.3M
$3.1M
Return on invested capital
3.84%
-32.89%
Return on assets
2.97%
-29.56%
Return on equity
6.9%
-38.66%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Jan
27
Balance Sheet
HYPMY
Sector
Total cash
$350M
$25.2M
Short term investments
--
$25.1M
Total assets
$4.5B
$73M
Long term debt
$1.4B
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
59
RGC alert for Jan 23
Regencell Bioscience Holdings Ltd. [RGC] is up 5.3% over the past day.
Buy
76
HYMC alert for Jan 23
Hycroft Mining Holding Corp. [HYMC] is up 8.35% over the past day.
Sell
24
INSP alert for Jan 23
Inspire Medical Systems, Inc. [INSP] is down 0.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
